Stay updated on Safety of ADSTEM Injection in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of ADSTEM Injection in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of ADSTEM Injection in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden message, replacing the previous study details and navigation.SummaryDifference15%

- Check55 days agoChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous v3.6.6, signaling a version update without altering the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing v3.6.5. This indicates a behind-the-scenes update to the page.SummaryDifference0.1%

Stay in the know with updates to Safety of ADSTEM Injection in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ADSTEM Injection in Atopic Dermatitis Clinical Trial page.